Mob: +61 407 690 401
Fax: +61 3 9830 1005
Email: phillip@phillip
University Web Page: click here
Biotechnology and Pharmaceutical Consultant | Expertise in pharmacokinetic | Particular interest in antivirals for influenza | 65 scientific publications including 3 book chapters and inventor on 3 published patents |
- Phillip Reece is a consultant expert with over 30 years experience in the research and development of human pharmaceuticals
- Trained in organic chemistry at the University of Adelaide and medical chemistry at the Australian National University, Canberra
- Undertook clinical pharmacology research at the Queen Elizabeth Hospital, an Adelaide U
niversity teaching hospital, for 12 years before joining Astra Pharmaceuticals , Sydney in 1987 - Appointed Director of Clinical Pharmacology, Parke Davis, Ann Arbor, MI, USA in 1990 and responsible for the development of CNS drugs.
- Appointed Director of Researc
h and Development in 1993 at Biota Holdings, one of Australia’s leading biotechnology companies and founder of the influenza antiviral, zanamivir - Since 2002 held several senior industry roles including CEO of Boron Molecular, a fine chemicals company, Chairman of Cryptopharma, an early stage biotechnologyco
mpany developing new antiinflammator y drugs, and non-executive Director of EnGeneIC, a privately held company developing a new vehicle for delivering anticancer drugs - Acted as a consultant expert to lawyers engaged in one of Australia’s largest commercial litigation cases. This involved communicating complex scientific issues to the legal team, assisting in the preparation of questions for expert witnesses, and preparing technical reports, chronologies and literature reviews for the case
- Consultant expert in the areas of pharmaceutical developmen
t, clinical trials, pharmacokinetic s, pharmacodynamic s and intellectual property matters to biotechnology companies, pharmaceutical companies and law firms - 65 scientific publications in the areas of human pharmacokinetic
s, clinical trials, respiratory antivirals particularly for influenza, anticancer drugs and antihypertensiv es; 3 book chapters on antihypertensiv es and an inventor on three published patents in the area of respiratory antivirals
SEE: Resume,FAQs,Publications,Presentations,Patents,Details of Recent Appointments
